NADOLOL ELIMINATION BY PATIENTS WITH RENAL IMPAIRMENT
| dc.contributor.author | VUKOVICH, RA | |
| dc.contributor.author | HERRERA, JOSE MANUEL DE | |
| dc.contributor.author | GRIFFITH, DL | |
| dc.date.accessioned | 2026-05-28T16:52:54Z | |
| dc.date.issued | 1978 | |
| dc.description.paginacion | 133 - 133 | |
| dc.description.procedencia | EXT | |
| dc.format.discurso | Resumen de reunión | |
| dc.format.extent | 1 | |
| dc.identifier.issn | 0009-9236 | |
| dc.identifier.uri | https://ahcm.cinvestav.mx/handle/ahcm/29121 | |
| dc.language.iso | Inglés | |
| dc.numero.secuencia | 29118 | |
| dc.publisher | SQUIBB INST MED RES,PRINCETON,NJ 08540 | |
| dc.publisher | NATL INST NUTR,MEXICO CITY,MEXICO | |
| dc.relation.ispartofseries | Vol. 23 No. 1 | |
| dc.source.revistafuente | CLINICAL PHARMACOLOGY & THERAPEUTICS | |
| dc.subject | NADOLOL, PATIENTS, RENAL IMPAIRMENT | |
| dc.subject.categoriaprincipal | CIENCIAS MEDICAS | |
| dc.subject.disciplina | FARMACOLOGIA | |
| dc.subject.subdisciplina | FARMACOLOGIA EXPERIMENTAL | |
| dc.title | NADOLOL ELIMINATION BY PATIENTS WITH RENAL IMPAIRMENT | |
| dc.title.alternative | CLIN PHARMACOL THER |
